Insulin resistance, elevated hepatic glucose output, and β-cell dysfunction are the factors that describe type 2 diabetes (T2D) (
1). Diabetic patients can be characterized by weakened protein, lipid, and carbohydrate metabolism and high levels of fasting blood glucose (
2). Muscles, eyes, blood vessels, heart, and kidneys are the important organs affected in diabetes-induced chronic hyperglycemia. Hence, muscular atrophy, retinopathy, cardiac dysfunction, atherosclerosis, and nephropathy are T2D-induced complications. To improve T2D, insulin sensitivity and glucose homeostasis are considered as effective treatments. AMP-activated protein kinase (AMPK) is a sensor of energy that diminishes hepatic glucose production, stimulates fatty acid oxidation in the adipose, and induces glucose uptake in the skeletal muscles. The activation of AMPK causes insulin sensitivity, and therefore AMPK is an attractive therapeutic target for T2D (
1). Another potential AMPK target is nuclear respiratory factor 1 (NRF1), which is needed for the coordinated expression of a multitude of nuclear- and mitochondrial-encoded enzymes found within the mitochondrial respiratory chain. AMPK increases the expression of NRF1. Today, recent studies focus on anti-diabetic natural antioxidants, which improve oxidative stress and inflammation in obesity and T2D. Crocin is a natural carotenoid found in saffron, which is responsible for the color of saffron and can induce its metabolic effects through the increase of antioxidants (
3). Research shows that crocin has neuro-protective, anti-platelet, anti-hyperlipidemic, anti-carcinogenic, and antioxidant properties (
4). Previous studies reported the anti-oxidative and hypoglycemic properties of crocin in diabetic rats (
5). Accordingly, it was shown that in diabetic rats, blood glucose level significantly reduced by the administration of 60 mg/kg of crocin in the kidneys and liver. Also, administration of 50 and 100 mg/kg of crocin significantly decreased serum glucose, triglyceride, total cholesterol, advanced glycation end products (AGEs), and low-density lipoprotein (LDL) levels in diabetic rats while increasing high-density lipoprotein (HDL) (
6). It is reported that both high-intensity interval training (HIIT) and low-intensity continued training (LICT) can improve lipids and blood glucose metabolism. Accordingly, physical activity along with exercise modifications can be used in T2D treatment (
7). Furthermore, exercise can increase insulin sensitivity and FOXO1 expression and reduce blood lipid profiles and glycated hemoglobin (HbA1c) (
7). The results of various studies have shown that exercise in interaction with the use of antioxidants can have positive effects on the improvement of diabetes and its impairments. In this vein, it has been shown that four weeks of consuming coriander extract with endurance training had interactive hypoglycemic effects in diabetic rats (
8). Also, simultanous consumption of saffron with resistance training significantly improved the glycemic indices of diabetic rats (
9).